Discovery and evaluation of triple inhibitors of VEGFR-2, TIE-2 and EphB4 as anti-angiogenic and anti-cancer agents-Reference-Cited by-同舟云学术

Discovery and evaluation of triple inhibitors of VEGFR-2, TIE-2 and EphB4 as anti-angiogenic and anti-cancer agents

Published:2017-08-08 Issue:62 Volume:8 Page:104745-104760
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Zhang Lin¹,Shan Yuanyuan²,Ji Xingyue³,Zhu Mengyuan³,Li Chuansheng¹,Sun Ying¹,Si Ru¹,Pan Xiaoyan¹,Wang Jinfeng¹,Ma Weina¹,Dai Bingling¹,Wang Binghe³,Zhang Jie¹

Affiliation:

1. School of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an, China

2. Department of Pharmacy, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China

3. Department of Chemistry and Center for Diagnostics and Therapeutics, Georgia State University, Atlanta, Georgia, United States

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Thiazolidine‐2,4‐Dione Derivatives as Potential VEGFR‐2 Inhibitors: Synthesis, Biological Testing, and in Silico Studies;ChemistrySelect;2024-03-15

2. Biological Significance of EphB4 Expression in Cancer;Current Protein & Peptide Science;2024-03

3. Novel quinazolines bearing 1,3,4-thiadiazole-aryl urea derivative as anticancer agents: design, synthesis, molecular docking, DFT and bioactivity evaluations;BMC Chemistry;2024-02-12

4. Quinazoline-based VEGFR-2 inhibitors as potential anti-angiogenic agents: A contemporary perspective of SAR and molecular docking studies;European Journal of Medicinal Chemistry;2023-11

5. A Review on the Anticancer Activity of Carbazole-based Tricyclic Compounds;Current Medicinal Chemistry;2023-10-19